Company / Profit Margin
Foghorn Therapeutics Inc. Profit Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-383.2%
FY2025
5-year range
-16000.0% / -288.2%
FY2021-FY2025
Trend
-33.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -566.3% to -383.2% over the past 2 years.
Based on SEC 10-K filings.
-383.2% in FY2025 with a 5-year CAGR of +11507.0%.
Improved from -566.3% to -383.2% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +7298.3pp
- 5-Year Change
- +11507.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 33.0% year-over-year.
- Peak profit margin was recorded in FY2024.
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -383.2% | -33.0% |
| FY2024 | -288.2% | +49.1% |
| FY2023 | -566.3% | +92.6% |
| FY2022 | -7681.6% | +52.0% |
| FY2021 | -16000.0% | -34.6% |
| FY2020 | -11890.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026